drugset / Trial / NCT05631717

The Study of Comparing the Efficacy and Safety of Human Umbilical Cord MSCs and Low-dose IL-2 in the Treatment of LN

NCT05631717

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare the efficacy and safety of human umbilical cord mesenchymal stem cells and low-dose IL-2 in the treatment of LN

Timeline

Start
2022-10-01
Primary completion
2025-06
Completion
2025-12-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject aldesleukin Protein / enzyme biologic 1e+06 iu Subcutaneous
Subject human umbilical cord mesenchymal stem cells Cell therapy 1e+06 cells/kg Intravenous